Novartis (Sintrom) is Buildings and Property in Switzerland that focus on blood clots business. They cover business area such as right, brand prescription medicine product Sintrom, prevention, treatment, venous thrombosis, blood clot, atrial fibrillation, embolization, irregular heart rhythm, obstruction, pulmonary embolism, an adjunct, coronary occlusion, (blockage, cerebral ischemic attack, a mild form, stroke.
-
Blood Clots
-
Lichtstrasse 35
4056 Basel
Switzerland
Private
rightbrand prescription medicine product Sintrompreventiontreatmentvenous thrombosisblood clotatrial fibrillationembolizationirregular heart rhythmobstructionpulmonary embolisman adjunctcoronary occlusion(blockagecerebral ischemic attacka mild formstroke
* We use standard office opening hours in near Novartis (Sintrom)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Novartis (Sintrom) is Buildings and Property business from Switzerland that founded in - ( years old in ), Novartis (Sintrom) business is focusing on Blood Clots.
Novartis (Sintrom) headquarter office and corporate office address is located in Lichtstrasse 35 4056 Basel Switzerland.
Novartis (Sintrom) was founded in Switzerland.
In , Novartis (Sintrom) is currently focus on blood clots sector.
Above is snippet of Google Trends for "blood clots" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Novartis (Sintrom), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
